ACTIMIS PHARMACEUTICALS, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C07D HETEROCYCLIC COMPOUNDS 11151
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 7248
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 392
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 247

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9206164 Pyrazole compounds as CRTH2 antagonistsMar 15, 12Dec 08, 15[A61K, C07D]
8859770 Process for preparing [4,6-bis-dimethylamino-2-[4-(4-trifluoromethylbenzoylamino)benzyl]pyrimidin-5-yl]acetic acidMay 07, 12Oct 14, 14[C07D]
8791272 Pyrazole compounds as CRTH2 antagonistsJan 24, 11Jul 29, 14[A61K, C07D]
8759386 Pyrazole compounds as CRTH2 antagonistsJan 19, 12Jun 24, 14[A61K, C07D]
8541419 Isotopically enriched pyrimidin-5-yl acetic acid derivatives as CRTH2 antagonistsSep 01, 09Sep 24, 13[A01N, C07D]
8507005 Particulates of a CRTH2 antagonistJun 18, 08Aug 13, 13[A61K, C07D, A61P, B32B]
8324229 Alkylthio pyrimidines as CRTH2 antagonistsSep 24, 08Dec 04, 12[A61K, C07D]
8314116 2-S-benzyl substituted pyrimidines as CRTH2 antagonistsSep 24, 08Nov 20, 12[A61K, C07D]
8278310 Amine salts of a CRTH2 antagonistJun 18, 08Oct 02, 12[A01N, C07D]
7960393 Pyrimidine derivatives useful for the treatment of diseases mediated by CRTH2Aug 25, 10Jun 14, 11[A61K, C07D, A61P]

View all patents..

Expired/Abandoned/Withdrawn Patents

  • No Patents to Display

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.